Lifestyle trends and health tips
An Indonesian court's decision against patent evergreening signals a shift towards improved medicine access, resonating with patient advocates globally.
Heidi Overton's Senate hearing as FDA commissioner nominee underscores urgency in drug approvals, while states weigh Medicaid pricing choices.
Insurers are opposing Medicare's new proposal that alters how remote patient monitoring services are delivered, raising concerns over patient care management.
The U.S. faces its most significant measles outbreak in over three decades, with unvaccinated individuals suffering the worst consequences.
Gilead Sciences is ramping up its commitment to inflammation and immunology, crucial for its future growth alongside virology and oncology.
Heidi Overton's ascent from a small New Mexico town to FDA commissioner nominee reflects her commitment to public health and leadership.
Alkermes' Phase 1 trial of ALKS 7290, designed for sleep disorders, indicates potential effectiveness for ADHD with significant symptom reduction.
Pregnant and lactating individuals face barriers in finding relevant clinical trials due to a lack of structured data on their eligibility on ClinicalTrials.gov.
The FDA's approval of daraxonrasib provides new hope for pancreatic cancer patients, targeting the challenging KRAS mutation and improving survival rates significantly.
Zach Lahn, GOP candidate for Iowa governor, is leveraging RFK Jr.'s support amidst a challenging race against a Democratic opponent.
This article reflects on personal health struggles and the frustrations with today's medical system, highlighting a broader skepticism towards modern treatments.
Addiction clinics report a sharp rise in patients seeking help for kratom and 7-OH dependence amid growing warnings about these substances.
HCA Healthcare's Texas hospitals are suing Independence Blue Cross for $345,000 in claims, underlining persistent issues around prior authorization policies.
A geriatrician emphasizes the need for caution in utilizing AI predictions for older patients, noting potential impacts on care decisions.
Robert F. Kennedy Jr. introduces a new initiative to expedite autism diagnoses while addressing challenges in current methodologies.
Kennedy reinforced his anti-vaccine advocacy during a pivotal speech at a Children’s Health Defense conference, highlighting its significance ahead of upcoming elections.
The FDA has approved Fayuvi, the first gene therapy for Sanfilippo syndrome, offering hope to affected families and changing treatment dynamics.
Pennsylvania's measles outbreak has claimed a fourth life, highlighting a growing public health crisis as vaccination rates decline.
Robert F. Kennedy Jr. is set to speak at an anti-vaccine conference, marking his first major public appearance with the group since joining HHS.
The FDA's new pilot program aims to expedite the initiation of human testing for drugmakers, responding to industry demands for faster processes.